[Federal Register Volume 59, Number 208 (Friday, October 28, 1994)]
[Unknown Section]
[Page ]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-26709]


[Federal Register: October 28, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[CRADA NIO-95-001]


National Institute for Occupational Safety and Health; 
Cooperative Research and Development Agreement

AGENCY: Centers for Disease Control and Prevention (CDC), Public Health 
Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), National 
Institute for Occupational Safety and Health (NIOSH), announces the 
opportunity for potential collaborators to enter into a Cooperative 
Research and Development Agreement (CRADA) to develop a system or 
systems to automate sampling method development and analysis for 
airborne contaminants.
    It is anticipated that all inventions which may arise from this 
CRADA will be jointly owned. The collaborator(s) with whom the CRADA is 
made will have an option to negotiate an exclusive or non-exclusive 
royalty-bearing license. The CRADA will be executed for a 2-year period 
with the possibility of renewal for another 2-year period.
    Because CRADAs are designed to facilitate the development of 
scientific and technological knowledge into useful, marketable 
products, a great deal of freedom is given to Federal agencies in 
implementing collaborative research. The CDC may accept staff, 
facilities, equipment, supplies, and money from the other participants 
in a CRADA; CDC may provide staff, facilities, equipment, and supplies 
to the project. There is a single restriction in this exchange: CDC MAY 
NOT PROVIDE FUNDS to the other participants in a CRADA. This 
opportunity is available until 30 days after publication of this 
notice. Respondents may be provided a longer period of time to furnish 
additional information if CDC finds this necessary.

FOR FURTHER INFORMATION CONTACT: Technical: Eugene R. Kennedy, Ph.D., 
Methods Development Section 2, Methods Research Branch, Division of 
Physical Sciences and Engineering, NIOSH, CDC, 4676 Columbia Parkway, 
Mailstop R-7, Cincinnati, Ohio 45226, telephone, (513) 841-4392, FAX 
(513) 841-4500.
    Business: Theodore F. Schoenborn, Technology Transfer Coordinator, 
NIOSH, CDC, 4676 Columbia Parkway, Mailstop R-2, Cincinnati, Ohio 
45226, telephone, (513) 841-4305, FAX (513) 841-4500.

SUPPLEMENTARY INFORMATION: The system or systems to be developed will 
combine laboratory automation, with novel sampler designs and 
analytical methodology to provide for an automated approach to method 
development and evaluation. The collaborator(s) and NIOSH will jointly 
perform the research aimed at development of a commercial system to 
provide convenient sampling and analytical methods for airborne 
contaminants. NIOSH will provide technical expertise, consultation and 
guidance, verification of system integrity, and product evaluation and 
testing. Since this CRADA involves the bringing together of diverse 
technologies, a consortium of collaborators will be considered.
    Applicants will be judged according to the following criteria:
    1. Adequacy and technical capabilities to develop the desired 
technologies and product;
    2. Ability to develop, produce, market, and support system(s);
    3. Evidence of technical credibility; and
    4. Ability to complete the CRADA in a timely fashion.
    This CRADA is proposed and implemented under the 1986 Federal 
Technology Transfer Act: Public Law 99-502.
    The responses must be made to: Theodore F. Schoenborn, Technology 
Transfer Coordinator, National Institute for Occupational Safety and 
Health, CDC, 4676 Columbia Parkway, Mailstop R-2, Cincinnati, Ohio 
45226.

    Dated: October 24, 1994.
Richard A. Lemen,
Acting Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention (CDC).
[FR Doc. 94-26709 Filed 10-27-94; 8:45 am]
BILLING CODE 4163-19-P